BScPharm, MBA, LP.D.
Dr. Earl Ettienne is a licensed pharmacist, pharmacy and healthcare executive, researcher, and educator. He holds a degree in Pharmacy from the Howard University College of Pharmacy, a Residency Certificate in Clinical and Administrative Pharmacy from The Mt. Sinai Medical Center, New York, a certificate in Health Disparities: A Translational Research Approach from NIH/University of Puerto Rico, a Master’s in Business Administration from Loyola University, Maryland, certificate in Finance from Bryant University, Rhode Island and a Doctorate in Law and Policy from Northeastern University, Boston, Massachusetts where his doctoral work included using econometric analyses to make policy decisions at the country level. He is currently the Director of Graduate Programs and Industry Partnerships and an Associate Professor in Clinical and Administrative Pharmacy Sciences at the Howard University College of Pharmacy, serves as the Co-Chair of the University’s Institutional Review Board, is published, and is currently developing innovative programs at the graduate level in pharmacy surrounding genomics, policy, regulatory and medical affairs.
Prior to joining Howard University, Dr. Ettienne handled pharmacy operations and local government affairs in the Washington DC Metro Market for CVS Caremark, a Fortune 20 company with sales in excess of 75 billion dollars. He is a proven leader and has worked to craft, facilitate, and implement many pieces of legislation at both the federal and local levels. He testified before the United States Congress on the implementation of Medicare Part D representing the chain drug industry and before the DC City Council on technician licensing, pseudoephedrine diversion, vaccine administration by pharmacists, and the opioid use disorder crisis. Furthermore, he worked with the DC Board of Pharmacy to write and implement new regulations governing pharmacy practice. He sat on the Economic Advisory Council for Washington DC, the Board of Visitors for Howard University, the Loyola University Executive Alumni Association, the Pharmacy, and Therapeutics Committee for Washington DC and the Maryland Health Quality and Cost Council Cultural Competency Workgroup.
Dr. Ettienne has led research teams both locally and globally with the aim of using pharmacogenomics to improve clinical decision support in comorbid depression and diabetes, asthma management, opioid use disorder, and the use of traditional medicine. As a result of his work, he has participated in numerous poster and oral presentations, winning accolades for the “Best Overall Poster Presentation by Junior Faculty” and “First Place Oral Presentation.”
